These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


77 related items for PubMed ID: 7517084

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [The production of recombinant polypeptides from the herpes simplex viruses types 1 and 2].
    Zvonarev AIu, Shatalin KIu, Klichko VI, Karaseva EV, Kuliakina MN.
    Vopr Virusol; 1994; 39(3):110-3. PubMed ID: 8091748
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of an enzyme immunoassay system for measuring herpes simplex virus (HSV) type 1-specific and HSV type 2-specific IgG antibodies.
    Prince HE, Ernst CE, Hogrefe WR.
    J Clin Lab Anal; 2000; 14(1):13-6. PubMed ID: 10645979
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Escherichia coli expressed herpes simplex virus gG1 and gG2 proteins in ELISA and immunoblotting assays.
    Kakkanas A, Papadogeorgaki H, Manservigi R, Miriagou V, Georgopoulou U, Mavromara P.
    Intervirology; 1995; 38(6):346-51. PubMed ID: 8880385
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The glycoproteins C and G are equivalent target antigens for the determination of herpes simplex virus type 1-specific antibodies.
    Scheper T, Saschenbrecker S, Steinhagen K, Sauerbrei A, Suer W, Meyer W, Schlumberger W, Wandinger KP.
    J Virol Methods; 2010 Jun; 166(1-2):42-7. PubMed ID: 20171247
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of commercial herpes simplex virus IgG and IgM enzyme immunoassays.
    Liermann K, Schäfler A, Henke A, Sauerbrei A.
    J Virol Methods; 2014 Apr; 199():29-34. PubMed ID: 24418499
    [Abstract] [Full Text] [Related]

  • 11. Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions.
    Koelle DM, Corey L, Burke RL, Eisenberg RJ, Cohen GH, Pichyangkura R, Triezenberg SJ.
    J Virol; 1994 May; 68(5):2803-10. PubMed ID: 7512152
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay.
    Burbelo PD, Hoshino Y, Leahy H, Krogmann T, Hornung RL, Iadarola MJ, Cohen JI.
    Clin Vaccine Immunol; 2009 Mar; 16(3):366-71. PubMed ID: 19129469
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.